...
首页> 外文期刊>Plant Biotechnology Journal >Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection
【24h】

Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection

机译:在植物内质网中表达的口服免疫胰蛋白酶H5与佐剂皂苷,保护小鼠免受高致病性禽流感的病毒感染

获取原文
获取原文并翻译 | 示例

摘要

Pandemics in poultry caused by the highly pathogenic avian influenza (HPAI) A virus occur too frequently globally, and there is growing concern about the HPAI A virus due to the possibility of a pandemic among humans. Thus, it is important to develop a vaccine against HPAI suitable for both humans and animals. Various approaches are underway to develop such vaccines. In particular, an edible vaccine would be a convenient way to vaccinate poultry because of the behaviour of the animals. However, an edible vaccine is still not available. In this study, we developed a strategy of effective vaccination of mice by the oral administration of transgenic Arabidopsis plants (HA-TG) expressing haemagglutinin (HA) in the endoplasmic reticulum (ER). Expression of HA in the ER resulted in its high-level accumulation, N-glycosylation, protection from proteolytic degradation and long-term stability. Oral administration of HA-TG with saponin elicited high levels of HA-specific systemic IgG and mucosal IgA responses in mice, which resulted in protection against a lethal influenza virus infection with attenuated inflammatory symptoms. Based on these results, we propose that oral administration of freeze-dried leaf powders from transgenic plants expressing HA in the ER together with saponin is an attractive strategy for vaccination against influenza A virus.
机译:由高致病性禽流感(HPAI)引起的禽出血患者的病毒在全球范围内过于频繁出现,并且由于人类的大流行可能性,HPAI对病毒而言越来越担心。因此,对适合于人类和动物的HPAI开发疫苗非常重要。正在进行各种方法来发展这些疫苗。特别是,由于动物的行为,可食用的疫苗是疫苗疫苗的方便方法。然而,食用疫苗仍然不可用。在这项研究中,我们通过在内质网(ER)中表达血凝丙烯素(HA)的转基因拟南芥(HA-TG)进行了转基因拟南芥植物(HA-TG),开发了一种有效疫苗的策略。 HA在ER中的表达导致其高级积累,N-糖基化,保护免受蛋白水解降解和长期稳定性。 HA-TG与皂苷的口服施用高水平的小鼠HA特异性全身IgG和粘膜IgA反应,导致对致死性炎症症状的致死流感病毒感染保护。基于这些结果,我们提出了来自在ER中表达HA的转基因植物的冻干叶粉的口服施用与皂苷一起是一种有吸引力的抗甲型病毒疫苗的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号